Published in Anal Chem on June 15, 2010
A method of calculating the second dimension retention index in comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr A (2011) 1.28
An optimal peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using mixture similarity measure. Bioinformatics (2011) 1.22
MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Bioinformatics (2013) 1.06
Data preprocessing method for liquid chromatography-mass spectrometry based metabolomics. Anal Chem (2012) 1.01
Smith-Waterman peak alignment for comprehensive two-dimensional gas chromatography-mass spectrometry. BMC Bioinformatics (2011) 0.95
An empirical Bayes model using a competition score for metabolite identification in gas chromatography mass spectrometry. BMC Bioinformatics (2011) 0.94
Comparative analysis of mass spectral similarity measures on peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry. Comput Math Methods Med (2013) 0.91
Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. PLoS One (2013) 0.91
Model-based peak alignment of metabolomic profiling from comprehensive two-dimensional gas chromatography mass spectrometry. BMC Bioinformatics (2012) 0.90
Comparison of GC-MS and GC×GC-MS in the analysis of human serum samples for biomarker discovery. J Proteome Res (2015) 0.86
An efficient post-hoc integration method improving peak alignment of metabolomics data from GCxGC/TOF-MS. BMC Bioinformatics (2013) 0.84
A method of aligning peak lists generated by gas chromatography high-resolution mass spectrometry. Analyst (2013) 0.75
A Two-stage Peak Alignment Algorithm for Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry-Based Metabolomics. Comput Struct Biotechnol J (2013) 0.75
Global peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using point matching algorithms. J Bioinform Comput Biol (2016) 0.75
Occurrence of Emerging Micropollutants in Water Systems in Gauteng, Mpumalanga, and North West Provinces, South Africa. Int J Environ Res Public Health (2017) 0.75
Mass spectrometry-based metabolomics. Mass Spectrom Rev (2006) 5.23
A comprehensive two-dimensional retention time alignment algorithm to enhance chemometric analysis of comprehensive two-dimensional separation data. Anal Chem (2005) 1.55
Quantitative analysis of target components by comprehensive two-dimensional gas chromatography. J Chromatogr A (2003) 1.50
Objective data alignment and chemometric analysis of comprehensive two-dimensional separations with run-to-run peak shifting on both dimensions. Anal Chem (2001) 1.45
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta (2008) 1.43
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry peak sorting algorithm. J Chromatogr A (2007) 1.42
Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells. Anal Chem (2006) 1.25
Two-dimensional correlation optimized warping algorithm for aligning GC x GC-MS data. Anal Chem (2008) 1.25
Application of a metabolomic method combining one-dimensional and two-dimensional gas chromatography-time-of-flight/mass spectrometry to metabolic phenotyping of natural variants in rice. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.23
Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics. Anal Chem (2007) 1.19
Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J Chromatogr A (2005) 1.10
Algorithm for locating analytes of interest based on mass spectral similarity in GC x GC-TOF-MS data: analysis of metabolites in human infant urine. J Chromatogr A (2004) 1.08
Identification and evaluation of cycling yeast metabolites in two-dimensional comprehensive gas chromatography-time-of-flight-mass spectrometry data. J Chromatogr A (2007) 1.05
Differential metabolomics using stable isotope labeling and two-dimensional gas chromatography with time-of-flight mass spectrometry. Anal Chem (2007) 1.01
Comprehensive analysis of yeast metabolite GC x GC-TOFMS data: combining discovery-mode and deconvolution chemometric software. Analyst (2007) 1.00
Metabolite profiling analysis of Methylobacterium extorquens AM1 by comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry. Biotechnol Bioeng (2008) 0.98
Comprehensive two-dimensional gas chromatography with fast enantioseparation. Anal Chem (2002) 0.97
Recent advancements in comprehensive two-dimensional separations with chemometrics. J Chromatogr A (2007) 0.97
A review of basic concepts in comprehensive two-dimensional gas chromatography. J Chromatogr Sci (2002) 0.95
A comprehensive gas chromatography coupled to high resolution mass spectrometry based method for the determination of polybrominated diphenyl ethers and their hydroxylated and methoxylated metabolites in environmental samples. J Chromatogr A (2009) 0.90
Higher mass loadability in comprehensive two-dimensional gas chromatography-mass spectrometry for improved analytical performance in metabolomics analysis. J Chromatogr A (2007) 0.87
Acquisition of deeper knowledge on the human plasma fatty acid profile exploiting comprehensive 2-D GC. J Sep Sci (2008) 0.83
Chemotaxonomy of bacteria by comprehensive GC and GC-MS in electron impact and chemical ionisation mode. J Sep Sci (2008) 0.82
Headspace solid-phase microextraction--comprehensive two-dimensional gas chromatography of wound induced plant volatile organic compound emissions. Analyst (2002) 0.81
Two-dimensional separation method for analysis of Bacillus subtilis metabolites via hyphenation of micro-liquid chromatography and capillary electrophoresis. Anal Chem (2004) 0.81
Data processing technique in gas chromatography/time-of-flight mass spectrometry. Analyst (2009) 0.79
Sub-diffraction-limited optical imaging with a silver superlens. Science (2005) 7.67
Plasmon lasers at deep subwavelength scale. Nature (2009) 4.93
Three-dimensional optical metamaterial with a negative refractive index. Nature (2008) 4.87
A graphene-based broadband optical modulator. Nature (2011) 4.21
A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med (2009) 4.20
An optical cloak made of dielectrics. Nat Mater (2009) 4.16
Far-field optical hyperlens magnifying sub-diffraction-limited objects. Science (2007) 4.14
Optical negative refraction in bulk metamaterials of nanowires. Science (2008) 3.28
Ultrasonic metamaterials with negative modulus. Nat Mater (2006) 2.91
Plasmon-induced transparency in metamaterials. Phys Rev Lett (2008) 2.88
Experimental demonstration of an acoustic magnifying hyperlens. Nat Mater (2009) 2.82
Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51
c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology (2014) 2.04
Photonic spin Hall effect at metasurfaces. Science (2013) 2.04
Phase mismatch-free nonlinear propagation in optical zero-index materials. Science (2013) 1.90
Edge nonlinear optics on a MoS₂ atomic monolayer. Science (2014) 1.83
Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One (2013) 1.81
Room-temperature sub-diffraction-limited plasmon laser by total internal reflection. Nat Mater (2010) 1.73
Switching terahertz waves with gate-controlled active graphene metamaterials. Nat Mater (2012) 1.72
Probing the electromagnetic field of a 15-nanometre hotspot by single molecule imaging. Nature (2011) 1.72
Space-time crystals of trapped ions. Phys Rev Lett (2012) 1.71
Photoinduced handedness switching in terahertz chiral metamolecules. Nat Commun (2012) 1.69
Flying plasmonic lens in the near field for high-speed nanolithography. Nat Nanotechnol (2008) 1.65
Spherical hyperlens for two-dimensional sub-diffractional imaging at visible frequencies. Nat Commun (2010) 1.61
Transformational plasmon optics. Nano Lett (2010) 1.61
Plasmonic Luneburg and Eaton lenses. Nat Nanotechnol (2011) 1.59
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis. Blood (2009) 1.58
Double-layer graphene optical modulator. Nano Lett (2012) 1.56
A carpet cloak for visible light. Nano Lett (2011) 1.55
Negative refractive index in chiral metamaterials. Phys Rev Lett (2009) 1.55
High-Q surface-plasmon-polariton whispering-gallery microcavity. Nature (2009) 1.52
All optical interface for parallel, remote, and spatiotemporal control of neuronal activity. Nano Lett (2007) 1.49
Wavelet- and Fourier-transform-based spectrum similarity approaches to compound identification in gas chromatography/mass spectrometry. Anal Chem (2011) 1.49
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell (2007) 1.45
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry peak sorting algorithm. J Chromatogr A (2007) 1.42
MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin. Biochem Biophys Res Commun (2012) 1.40
Far-field optical superlens. Nano Lett (2007) 1.39
Focusing surface plasmons with a plasmonic lens. Nano Lett (2005) 1.39
Common aspects of human and primate seronegative arthritis. J Rheumatol (2004) 1.39
Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol (2012) 1.37
Performance evaluation of existing de novo sequencing algorithms. J Proteome Res (2006) 1.36
Metamaterials: a new frontier of science and technology. Chem Soc Rev (2011) 1.34
Compound identification using partial and semipartial correlations for gas chromatography-mass spectrometry data. Anal Chem (2012) 1.34
Light-driven nanoscale plasmonic motors. Nat Nanotechnol (2010) 1.33
Observation of stimulated emission of surface plasmon polaritons. Nano Lett (2008) 1.32
Maskless plasmonic lithography at 22 nm resolution. Sci Rep (2011) 1.31
Cloaking of matter waves. Phys Rev Lett (2008) 1.28
A method of calculating the second dimension retention index in comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr A (2011) 1.28
Targeted comparative proteomics by liquid chromatography-tandem Fourier ion cyclotron resonance mass spectrometry. Anal Chem (2005) 1.28
A method of finding optimal weight factors for compound identification in gas chromatography-mass spectrometry. Bioinformatics (2012) 1.27
Axon initiation and growth cone turning on bound protein gradients. J Neurosci (2009) 1.27
Strong coupling of surface plasmon polaritons in monolayer graphene sheet arrays. Phys Rev Lett (2012) 1.27
Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci U S A (2011) 1.25
Automatic gain control in mass spectrometry using a jet disrupter electrode in an electrodynamic ion funnel. J Am Soc Mass Spectrom (2005) 1.23
MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett (2012) 1.22
An optimal peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using mixture similarity measure. Bioinformatics (2011) 1.22
Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res (2005) 1.21
Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop Med Int Health (2007) 1.21
Roles of GRP78 in physiology and cancer. J Cell Biochem (2010) 1.20
Subwavelength discrete solitons in nonlinear metamaterials. Phys Rev Lett (2007) 1.20
MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics. Anal Chem (2011) 1.19
Measuring financial protection for health in families with chronic conditions in Rural China. BMC Public Health (2012) 1.18
Neural network prediction of peptide separation in strong anion exchange chromatography. Bioinformatics (2006) 1.17
Passivation mechanism of thermal atomic layer-deposited Al2O3 films on silicon at different annealing temperatures. Nanoscale Res Lett (2013) 1.15
The effect of nonsense codons on splicing: a genomic analysis. RNA (2003) 1.15
Collisional activation of ions in RF ion traps and ion guides: the effective ion temperature treatment. J Am Soc Mass Spectrom (2004) 1.14
Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS (2004) 1.13
Development of optical hyperlens for imaging below the diffraction limit. Opt Express (2007) 1.13
Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas. Cancer (2005) 1.12
Nonparaxial Mathieu and Weber accelerating beams. Phys Rev Lett (2012) 1.11
iMatch: a retention index tool for analysis of gas chromatography-mass spectrometry data. J Chromatogr A (2011) 1.11
A hierarchical statistical model to assess the confidence of peptides and proteins inferred from tandem mass spectrometry. Bioinformatics (2007) 1.11
How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat Rev (2009) 1.10
Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10
Health-related quality of life in patients with high-grade glioma. Neuro Oncol (2008) 1.10
Heterojunction silicon microwire solar cells. Nano Lett (2012) 1.10
New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther (2007) 1.09
Expression of androgen receptor is negatively regulated by p53. Neoplasia (2007) 1.08
Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model. OMICS (2004) 1.08
Multiplexed and electrically modulated plasmon laser circuit. Nano Lett (2012) 1.08
Plasmonic Airy beams with dynamically controlled trajectories. Opt Lett (2011) 1.07
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15. Transl Oncol (2009) 1.06
Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease. J Proteome Res (2012) 1.06
MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Bioinformatics (2013) 1.06
Exacerbation of diabetes-induced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38 MAPK activation, and p53 activation in mice. Toxicol Lett (2010) 1.05
Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg (2008) 1.05
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci (2006) 1.04
Recent advances in transformation optics. Nanoscale (2012) 1.04
Experimental certification of random numbers via quantum contextuality. Sci Rep (2013) 1.04
Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways. Brain Res (2010) 1.03
HTreeQA: Using Semi-Perfect Phylogeny Trees in Quantitative Trait Loci Study on Genotype Data. G3 (Bethesda) (2012) 1.03
An optical "Janus" device for integrated photonics. Adv Mater (2010) 1.03